David J. Sugarbaker

Medicine · Health Sciences

94h-index41.2kcitations595works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Occupational and environmental lung diseases(213), Pleural and Pulmonary Diseases(148), Lung Cancer Diagnosis and Treatment(110), Medical Imaging and Pathology Studies(96), Lung Cancer Treatments and Mutations(88)

Publications590 total

Tratado de Cirurgia Torácica
Even3 Publicações eBooks·2024
Data from Expression of Interleukin-4 Receptor Alpha in Human Pleural Mesothelioma Is Associated with Poor Survival and Promotion of Tumor Inflammation
2023Open Access
Supplementary Table S1 from Validation of Genomics-Based Prognostic Tests in Malignant Pleural Mesothelioma
2023Open Access
Supplementary Figure Legends 1-2 from Expression of Interleukin-4 Receptor Alpha in Human Pleural Mesothelioma Is Associated with Poor Survival and Promotion of Tumor Inflammation
2023Open Access
Supplementary Figure 2 from Progression of EGFR-Mutant Lung Adenocarcinoma is Driven By Alveolar Macrophages
2023Open Access
Supplementary Figures and Tables from Genomic Analysis of Thymic Epithelial Tumors Identifies Novel Subtypes Associated with Distinct Clinical Features
2023Open Access
Data from Genomic Analysis of Thymic Epithelial Tumors Identifies Novel Subtypes Associated with Distinct Clinical Features
2023Open Access
Data from Validation of Genomics-Based Prognostic Tests in Malignant Pleural Mesothelioma
2023Open Access
Supplementary Figure 2 from Expression of Interleukin-4 Receptor Alpha in Human Pleural Mesothelioma Is Associated with Poor Survival and Promotion of Tumor Inflammation
2023Open Access
Data from Validation of Genomics-Based Prognostic Tests in Malignant Pleural Mesothelioma
2023Open Access
Supplementary Figure 2 from Expression of Interleukin-4 Receptor Alpha in Human Pleural Mesothelioma Is Associated with Poor Survival and Promotion of Tumor Inflammation
2023Open Access
Supplementary Table 2 from Expression of Interleukin-4 Receptor Alpha in Human Pleural Mesothelioma Is Associated with Poor Survival and Promotion of Tumor Inflammation
2023Open Access
Data from <i>EML4-ALK</i> Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung Cancer
2023Open Access
Supplementary Figure 3 from Progression of EGFR-Mutant Lung Adenocarcinoma is Driven By Alveolar Macrophages
2023Open Access
Supplementary Figure 1 from Progression of EGFR-Mutant Lung Adenocarcinoma is Driven By Alveolar Macrophages
2023Open Access
Supplementary Table 1 from Expression of Interleukin-4 Receptor Alpha in Human Pleural Mesothelioma Is Associated with Poor Survival and Promotion of Tumor Inflammation
2023Open Access
Supplementary Table S3 from Validation of Genomics-Based Prognostic Tests in Malignant Pleural Mesothelioma
2023Open Access
Supplementary Table S3 from Validation of Genomics-Based Prognostic Tests in Malignant Pleural Mesothelioma
2023Open Access
Supplementary Figure 2 from Progression of EGFR-Mutant Lung Adenocarcinoma is Driven By Alveolar Macrophages
2023Open Access
Supplementary Figure 1 from Expression of Interleukin-4 Receptor Alpha in Human Pleural Mesothelioma Is Associated with Poor Survival and Promotion of Tumor Inflammation
2023Open Access
page 1 of 30Next →

Frequent Co-authors

William G. Richards(21), Raphael Bueno(14), Michael T. Jaklitsch(12), Steven Swanson(11), Gary M. Strauss(10), Steven J. Mentzer(10), James E. Herndon(7), Malcolm M. DeCamp(6), Matthew Meyerson(5), Jeanne M. Lukanich(5), Elizabeth H. Baldini(5), Pasi A. Jänne(5), Michael A. Maddaus(4), David H. Harpole(4), Raphael Bueno(4), Gavin J. Gordon(4), Ravi Salgia(4), Katsuhiko Naoki(4), Jun Li(4), Thomas H. Lee(3)